Updated:
Biotechnology Industry Research Assistance Council
Biotechnology Industry Research Assistance Council was established in 2015 as a public sector undertaking under the Department of Biotechnology, Ministry of...
Biotechnology Industry Research Assistance Council
Biotechnology Industry Research Assistance Council was established in 2015 as a public sector undertaking under the Department of Biotechnology, Ministry of Science & Technology. The council channels capital into biotechnology projects through grants and assistance programs. Confirmed partners include the Bill & Melinda Gates Foundation on Grand Challenges India, the World Bank on the National Biopharma Mission, and the Wellcome Trust on translational research. Activity centers on India with co-investment structures involving TATA Trust-Social Alpha. No headcount or additional offices are disclosed. The council collaborates with the Association of Biotechnology Led Enterprises on the India BioEconomy Report and operates Grand Challenges India as an adjacent initiative. Governance ties directly to the Department of Biotechnology as founder and parent body, creating a public mandate that shapes deployment toward national biotechnology priorities rather than private returns.
General information
Firm type
Government / Public Body
Year founded
2015
Location
Region
Asia
Country
India
City
New Delhi
Corporate office
5th Floor, NSIC Business Park, NSIC Bhawan, Okhla Industrial Estate, New Delhi - 110020, India
Sector focus
Frequently asked questions
Who oversees Biotechnology Industry Research Assistance Council?
The Department of Biotechnology, Ministry of Science & Technology, established BIRAC as a public sector undertaking.
What partnerships support BIRAC programs?
BIRAC works with the Bill & Melinda Gates Foundation on Grand Challenges India and with the World Bank on the National Biopharma Mission.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: